Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach
Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Apr 8, 2021
Trial Information
Current as of September 11, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is studying whether the length of the bypassed intestine in gastric bypass surgery affects how much weight people lose and how their body’s metabolism improves, including effects on gut hormones, gut bacteria, and certain blood markers called microRNAs. It uses a randomized design with five groups: three different lengths of the bypass (50 cm, 100 cm, and 150 cm), plus two control groups (a sleeve gastrectomy and a best non-surgical medical weight-loss program). The study will compare weight loss and health improvements (like diabetes and cholesterol) and will also look for possible complications related to malabsorption. It is being conducted at the University of Missouri-Columbia and is currently enrolling by invitation, with results not yet available.
If you’re eligible, you’d be an adult between 18 and 80 with a body mass index (BMI) of 40–60, and you’d need to meet your insurance criteria for weight-loss surgery. Eligible participants could be randomized to one of the three bypass lengths, or to sleeve gastrectomy, or to medical therapy. Those in the surgical groups would have a standard laparoscopic procedure, and all participants would provide blood samples before surgery and again at about 6 and 12 months, plus stool samples at the same times. Researchers will track weight, diabetes status, and lipid levels, and will monitor for any surgery-related complications. Data from the study will be shared in a de-identified way with other researchers to help understand the biology behind weight loss after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age greater than 18
- • 2. Body mass index of 40-60 kg/m2
- • 3. Meet insurance criteria, as set forth by the patient's insurance policy, to qualify for coverage for weight loss surgery
- • 4. Planned laparoscopic Roux-en-Y gastric bypass
- • 5. Willingness to have blood collected before and after surgical procedure at defined points and collect and mail stool sample before operation and at defined post-operative time points.
- Exclusion Criteria:
- • 1. Age less than 18
- • 2. Patient fails to fulfill insurance mandated criteria
- • 3. Unwilling to be randomized to variable length to gastric bypass or unwilling to have blood collected or personally collect and mail in stool sample
- • 4. Unwilling to follow-up at required postoperative visits
About University Of Missouri Columbia
The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
Patients applied
Trial Officials
Andrew Wheeler, MD
Principal Investigator
University of Missouri-Columbia, Department of Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials